Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Recruiting · NCT07607587 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-06-25 | NCT07607587 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novo Nordisk A/S | 181 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Accellacare | Wilmington | United States | 6 |
| Amarillo Medical Specialists | Amarillo | United States | 6 |
| Center for Diab,Obes & Metab | Pembroke Pines | United States | 5 |
| Coastal Carolina Research Ctr | North Charleston | United States | 5 |
| Diablo Clinical Research, Inc. | Walnut Creek | United States | 30 |
| Elligo Clin Res Centre | Austin | United States | 1 |
| Encore Medical Research of Weston | Weston | United States | 7 |
| Holston Medical Group_Bristol | Bristol | United States | 6 |
| Jacksonville Ctr for Clin Res | Jacksonville | United States | 5 |
| Monroe Biomedical Research, LLC | Monroe | United States | 1 |
| Northeast Research Institute | Fleming Island | United States | 11 |